TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 39 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $25,000 | +108.3% | 18,056 | -6.7% | 0.00% | – |
| Q4 2018 | $12,000 | -70.0% | 19,354 | 0.0% | 0.00% | – |
| Q3 2018 | $40,000 | -47.4% | 19,354 | -31.3% | 0.00% | – |
| Q2 2018 | $76,000 | -65.3% | 28,154 | -70.4% | 0.00% | – |
| Q1 2018 | $219,000 | -32.0% | 95,069 | -1.2% | 0.00% | -100.0% |
| Q4 2017 | $322,000 | +17.9% | 96,250 | +10.9% | 0.00% | 0.0% |
| Q3 2017 | $273,000 | +64.5% | 86,800 | +25.4% | 0.00% | – |
| Q2 2017 | $166,000 | – | 69,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 4,601,768 | $2,899,000 | 3.31% |
| Telemetry Investments, L.L.C. | 966,975 | $609,000 | 0.39% |
| 683 Capital Management, LLC | 2,738,938 | $1,726,000 | 0.10% |
| Anson Funds Management LP | 250,182 | $158,000 | 0.09% |
| NEA Management Company, LLC | 3,467,181 | $2,184,000 | 0.09% |
| LINDEN ADVISORS LP | 2,842,477 | $1,791,000 | 0.05% |
| X-Square Capital, LLC | 79,198 | $50,000 | 0.04% |
| QVT Financial LP | 23,351 | $15,000 | 0.01% |
| BHK Investment Advisors, LLC | 10,000 | $6,000 | 0.01% |
| Virtu Financial LLC | 18,233 | $11,000 | 0.00% |